Patient Care Law Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Patient Care Law Weekly


We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Frost & Sullivan

Officials from Frost & Sullivan detail the latest developments

This trend article is an immediate alert from NewsRx to identify the most recent news developments at Frost & Sullivan.

Report 1: Despite its promising potential, industry participants remain wary of the European market for continuous glucose monitoring systems due to concerns over reimbursement and acceptance by conservative clinicians. However, the projected integration of systems with insulin pumps will support market expansion.

Frost & Sullivan finds that the European continuous glucose monitoring systems market earned revenues of US$14.0 million in 2006 and is...

• View Other Issues of Patient Care Law Weekly
  
• View Other NewsRx Publications